Skip to main content

Palmer receives fourth new NIH R01 in 2021

red blood cells

In an incredible achievement, Ohio Eminent Scholar Andre Palmer has received his fourth NIH R01 grant in 2021.

In mid-December, Palmer learned that he had been newly awarded a $2.6M grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) as a multi-PI with the University of Maryland Baltimore as the lead institution. The title of the grant is  “Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis.” The major goal of this work is to develop a protein complex therapeutic to detoxify hemolysis byproducts in cardiopulmonary bypass circuits.

Earlier in December, Palmer was selected as one of three principal investigators on a $2.5M grant, along with the University of Colorado-Denver as the lead institution and the University of Maryland. The project title is "Aerosolized therapy for hemoglobin toxicity in the treatment of hemolytic diseases." The major goal of this work is to develop a protein cocktail aerosol therapeutic to detoxify hemolysis byproducts in genetic and acquired anemias.  

The first project, titled "Engineering a novel biomaterial for oxygen transport applications,” received $2.7M. The second project, titled “Bioengineering a Dual Function Protein Construct to Detoxify Heme and Hemoglobin," received $2.6M.

The NIH R01 Research Project Grant is the original and historically oldest grant mechanism used by NIH. The R01 provides support for health-related research and development based on the mission of the NIH. The goals of the agency are to ultimately protect and improve health via creative research discoveries and applications; to develop scientific human and physical resources that will ensure the Nation's capability to prevent disease; to enhance economic well-being and ensure a continued high return on public investment in research; and to exemplify and promote the highest level of scientific integrity, accountability, and social responsibility in the conduct of science.

In August of this year, Palmer was named associate dean for research of the College of Engineering. As associate dean, he will lead the research endeavors of faculty and staff, oversee the college’s research operations—totaling more than $138 million in annual research expenditures—and grow strategic industry partnerships. 

Palmer also received the 2021 Gaden Award this year from the journal Biotechnology & Bioengineering (Wiley) in recognition of a "truly outstanding paper."

He served as chairman of Ohio State's William G. Lowrie Department of Chemical and Biomolecular Engineering from 2015-2019 and is a fellow of the American Institute for Medical and Biological Engineering (AIMBE).


Category: Faculty